Secondary Logo

March 1, 2019 - Volume 33 - Issue 3
pp: N1-N4,363-596

Eliminating perinatal HIV in the United States: mission possible?

Gnanashanmugam, Devasena; Rakhmanina, Natella; Crawford, Keith W.; More

AIDS. 33(3):377-385, March 1, 2019.

HIV controllers suppress viral replication and evolution and prevent disease progression following intersubtype HIV-1 superinfection

de Azevedo, Suwellen S.D.; Delatorre, Edson; Côrtes, Fernanda H.; More

AIDS. 33(3):399-410, March 1, 2019.


Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects

Pérez-Valero, Ignacio; Ellis, Ronald; Heaton, Robert; More

AIDS. 33(3):475-481, March 1, 2019.

Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment

Bellagamba, Rita; Giancola, Maria Letizia; Tommasi, Chiara; More

AIDS. 33(3):493-502, March 1, 2019.


Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal diet

Connor, Ruth I.; Zain-ul-Abideen, Muhammad; Magohe, Albert K.; More

AIDS. 33(3):509-514, March 1, 2019.

GlycA, a novel inflammatory marker, is associated with subclinical coronary disease

Tibuakuu, Martin; Fashanu, Oluwaseun E.; Zhao, Di; More

AIDS. 33(3):547-557, March 1, 2019.

Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression

Turan, Bulent; Rice, Whitney S.; Crockett, Kaylee B.; More

AIDS. 33(3):571-576, March 1, 2019.